Search results
Spotlight on Pfizer: Analyzing the Surge in Options Activity - Pfizer (NYSE:PFE)
Benzinga· 2 days agoLoading... Loading... Whales with a lot of money to spend have taken a noticeably bearish stance on Pfizer . Looking at options history for Pfizer PFE we ...
Analyst Report: Pfizer Inc.
Argus Research via Yahoo Finance· 2 days agoPfizer is a leading developer and manufacturer of pharmaceuticals and biotech drugs. Its products include oncology and immunology drugs, treatments for rare diseases, and vaccines.
Pfizer agrees to settle over 10,000 Zantac lawsuits
New Hampshire Union Leader· 4 days agoPfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported...
Second Death - Pfizer Reports Young Boy's Death After One Year Of Gene Therapy Treatment In Muscle...
Benzinga· 3 days agoA young patient died due to cardiac arrest after receiving Pfizer Inc’s PFE experimental gene...
Pfizer agrees to settle over 10,000 Zantac lawsuits, Bloomberg News reports By Reuters
Investing.com· 4 days agoThe agreements cover cases in U.S. state courts but don't completely resolve the company's exposure...
2 No-Brainer Dividend Stocks to Buy in May
Motley Fool via Yahoo Finance· 3 days agoWhich dividend stocks are worth buying in the current market? Telecom giant AT&T (NYSE: T) and pharmaceutical titan Pfizer (NYSE: PFE) scan as incredible...
Pfizer reports patient death in Duchenne gene therapy study
KFGO· 4 days ago(Reuters) - A young boy died due to a cardiac arrest in a mid-stage trial that tested Pfizer's...
Pfizer's Options Frenzy: What You Need to Know - Pfizer (NYSE:PFE)
Benzinga· 5 days agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Pfizer PFE , and it's something market players shouldn't ignore. Our tracking of public ...
Excellent Ratings for Pfizer's Property Captive in Vermont Are Affirmed
Insurance Journal· 2 days agoAM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit...
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever | The Motley Fool
The Motley Fool· 4 days agoHere is why Johnson & Johnson (JNJ -0.21%), Abbott Labs (ABT 0.04%), and Pfizer (PFE -0.55%) should...
